The approach to dialysis in developing countries

Complications of Dialysis

Volumn , Issue , 2000, Pages 811-822

  Jha, V ^a   Chugh, Kirpal S ^a   Chugh, Sumant ^b  

^a POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

^b BOSTON MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85007156273     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (53)

1. Annual Development Report 1995. Washington, DC: The World Bank, 1995.
2. Chugh KS, Jha V. Differences in the care of ESRD patients worldwide: required resources and future outlook. Kidney Int 1995; 48: S7-S13.
3. D’Amico G. Comparability of the different registries on renal replacement therapy. Am J Kidney Dis 1995; 25: 113-118.
4. Noronha IL, Schor N, Coelho SN, Jorgetti V, Romao Jr. FE, Zatz R, Burdmann EA. Nephrology, dialysis and transplantation in Brazil. Nephrol Dial Transplant 1997; 12: 2234-2243.
5. Fernandez JM, Schwedt E, Ambrosoni P, Gonzalez F, Mazzuchi N. Eleven years of chronic hemodialysis in Uruguay: Mortality time course. Kidney Int 1995; 47: 1721-1725.
6. Salah H. An overview of renal replacement therapy in Algeria. Saudi J Kidney Dis Transplant 1994; 5: 190-192.
7. Li L. End stage renal disease in China. Kidney Int 1996; 49: 287-301.
8. Jha V, Chugh KS. Dialysis in developing countries: priorities and obstacles. Nephrology 1996; 2: 65-72.
9. Mazzuchi N, Schwedt E, Fernandez JM, Cusumano AM, Ancao MS, Poblete H, Saldana-Arevalo M, Espinosa NR, Centurion C, Castillo H, Gonzalez F, Milanes CL, Infante M, Ariza M. Latin American registry of dialysis and renal transplantation: 1993 annual dialysis data report. Nephrol Dial Transplant 1997; 12: 2521-2527.
10. Barsoum RS. The Egyptian transplant experience. Transplant Proc 1992; 24: 2417-2420.
11. Lim TO, Lim YN, Tan CC, Lee DG, Morad Z. Malaysian dialysis and transplant registry report. Nephrology 1998; 4: 123-126.
12. Sakhuja V, Jha V, Ghosh AK, Ahmed S, Saha TK. Chronic renal failure in India. Nephrol Dial Transplant 1994, 9: 871-872.
13. Mani MK. The management of end-stage renal disease in India. Artif Organs 1997; 22: 182-186.
14. Rashid HU, Ahmed S, Rahman M, Hasan M, Noor Y, Mosaddeque M. Experience of hemodialysis in Bangladesh. In: Abstract Book, First International Congress on Dialysis in the Developing Countries, Singapore, November 2-5, 1994.
15. Kumar H, Alan F, Naqvi SA. Experience of hemodialysis at a kidney center. J Pak Med Assoc 1992; 42: 234-236.
16. Trevino-Becerra A. Development of artificial organs to treat chronic renal failure in Latin America. Artif Organs 1997; 22: 174-176.
17. Desai JD, Shah BV, Sirsat KA. Urea kinetics: a guide to dialysis prescription (abstr). Indian J Nephrol 1991; 1: 41.
18. Rutkowski B, Puka J, Lao M, Baczyk K, Chrzanowski W, Kokot F, Ksiazek A, Nartowicz E, Poplawski A, Sulowicz W, Scewcyzk Z. Renal replacement therapy in an era of socio-economic changes-report from the Polish registry. Nephrol Dial Transplant 1997; 12: 1105-1108.
19. Rutkowski B, Ciocalteu A, Djukanovic L, et al. Treatment of end-stage renal disease in central and eastern Europe: overview of current status and future needs. Artif Organs 1997; 22: 187-191.
20. Jain S, Chugh KS Morbidity and mortality burden of infections and infestations in chronic maintenance dialysis patients in developing countries. Proceedings of the First International Congress on Dialysis in the Developing Countries, Singapore, November 2-5, 1994.
21. Shah BV, Nair S, Sirsat RA, Ingle AV. Outcome of end stage renal disease: experience at a private hospital. Ind J Nephrol 1992; 2: 151-154.
22. Roesli RMA, Soedarsono S, Soedarsono W. Patient to patient insurance system. A system to help hemodialysis patients in Indonesia. In: Abstract Book, First International Congress on Dialysis in the Developing Countries, Singapore, November 2-5, 1994.
23. Pingle A, Shakuntala RV, Chowdhry Y, Menon J, Pingle S. Presentation, treatment and outcome of tuberculosis in an oriental population with end-stage renal disease. In: Abstract Book, First International Congress on Dialysis in the Developing Countries, Singapore, November 2-5, 1994.
24. Zhang X, Hou F, Wei D. Tuberculosis in chronic renal failure patients with or without renal replacement therapy. Chung Hua Nei Ko Tsa Chih 1995; 34: 666-669.
25. Sulima-Gillow A, Rutkowski B, Kustosz J, Zdrojewski Z. Tuberculosis-an increasing risk for patients treated with long-term hemodialysis. Pol Arch Med Wewn 1994; 92: 251-259.
26. Cengiz K. Increased incidence of tuberculosis in patients undergoing hemodialysis. Nephron 1996; 73: 421-424.
27. Vasanth Kumari R, Jagannath K, Rajasekaran S. Bacteriological status and prevalence of drug resistance in district tuberculosis centers in Tamil Nadu. Lung India 1993; 9: 27-31.
28. John GT, Murugesam K, Jayaseelam L, Pulimood RB, Jacob CK, Shastry JCM. HLA phenotypes in Asians developing tuberculosis on dialysis or after renal transplantation (letter). Natl Med J India 1995; 8: 144.
29. Malhotra KK, Prabhakar S, Sharma RK, Dash SC, Singh RN. Hepatitis B in a hemodialysis unit in New Delhi. J Assoc Phys India 1985; 33: 216-217.
30. Thomas P, Kirubakaran MG, Jacob CK, Srinivasa NS, Hariharan S, John JT, Shastry JCM. Hepatitis B infection in a dialysis unit in South India. J Assoc Phys India 1987; 35: 284-285.
31. Kher V, Krishnamurthy G. Strategies against hepatitis B virus infection in renal failure patients: when, why and how? Ind J Nephrol 1996; 6: 137-141.
32. Anandh V, Dhanraj P, Nayyar V, Ballal HS. GM-CSF as an adjuvant to hepatitis B vaccination in hemodialysis patients. A preliminary report. Ind J Nephrol 1997; 7: 109-111.
33. Jha R, Kher V, Naik S, Elhence R, Gupta A, Sharma RK. Hepatitis B associated liver disease in dialysis patients: role of vaccination. J Nephrol 1994; 6: 98-102.
34. Krishnamurthy G, Kher V, Naki S. Increased incidence of hepatitis B virus infection among HBsAg vaccine low responder chronic renal failure patients on maintenance hemodialysis. Ind J Hematol Blood Trans 1994; 12: 2-6.
35. Salunkhe PM, Naik SR, Semwal SN, Naik S, Kher V. Prevalence of antibodies to hepatitis C virus in HBsAg negative hemodialysis patients. Indian J Gastroenterol, 1992; 11: 164-165.
36. Gunaydin M, Bedir A, Akpolat T, Kuku I, Pekbay A, Esen S, Ozyilkan E, Arik N, Cengiz K. Prevalence of serum HCV-RNA among hemodialysis patients in Turkey. Infection 1997; 25: 307-309.
37. Abdelnour GE, Matar GM, Sharara HM, Abdelnoor AM. Detection of anti-hepatitis C-virus antibodies and hepatitis C-virus RNA in Lebanese hemodialysis patients. Eur J Epidemiol 1997; 13: 863-867.
38. Huang CC. Hepatitis in patients with end-stage renal disease. J Gastroenterol Hepatol 1997; 12: S236-S241.
39. Bosmans JL, Nouwen EJ, Behets G, Gorteman K, Huraib SO, Shaheen FA, Maertens G, Verpooten GA, Elseviers MM, de Broe ME. Prevalence and clinical expression of HCV-genotypes in haemodialysis-patients of two geographically remote countries: Belgium and Saudi-Arabia. Clin Nephrol 1997; 47: 256-262.
40. Sakhuja V, Sud K, Maitra S, Jha V, Sehgal S, Chugh KS. Prevalence of HIV infection in a dialysis unit. Ind J Nephrol 1994; 4: 42-44.
41. Jochimsen EM, Carmichael WW, An J, Cardo DM, Cookson ST, Holmes CEM, de C. Antunes MG, de Melo Filho DA, Lyra TM, Barreto VST, Azevedo SMFO, Jarvis WR. Liver failure and death after exposure to microcystins at a hemodialysis center in Brazil. N Engl J Med 1998; 338: 873-878.
42. Sharma AK, Arora M, Gupta HP, Gupta R, Makkad PK. Energy intake and nutritional status in patients with end-stage renal disease. Ind J Nephrol 1997; 7: 97-99.
43. Roesma J. Renal nutritional problems in Indonesia: a study in two capital cities. In: Chugh KS, ed. Asian Nephrology. New Delhi: Oxford University Press, 1993: 656-661.
44. Saxena S, Jayraj PM, Mittal R, Shukla P, Agarwal SK, Tiwari SC, Dash SC. Clinical and laboratory features of patients with chronic renal failure at the start of dialysis in North India. Ind J Nephrol 1995; 5: 4-8.
45. Beheray SS, Shah BV. Dietary protein intake in Indian patients with chronic renal failure. Ind J Nephrol 1996; 6: 19-21.
46. Nissenson AR, Prichard SB, Cheng IKP, Gokal R, Kubota M, Maiorca R, Reilla MC, Rottembourg J, Steward JH. Non-medical factors that impact on ESRD modality selection. Kidney Int 1993; 43(suppl 40): S120-S127.
47. Santiago-Delpin EA, Cangiano JL. Renal disease and dialysis in Latin America. Transplant Proc 1991; 23: 1851-1854.
48. Zent R, Myers JE, Donald D, Rayner BL. Continuous ambulatory peritoneal dialysis: an option in the developing world. Perit Dial Int 1994; 14: 48-51.
49. El Matri A, ben Abdullah T, Kechrid C, Ben Maiz H, Ben Ayed H. Continuous ambulatory peritoneal dialysis in Tunisia. Nephrologie 1990; 11: 153-156.
50. Abraham G, Bhaskaran S, Soundarajan P, Ravi R, Nitya S, Padma G, Jayanthi V. Continuous ambulatory peritoneal dialysis. J Assoc Phys India 1996; 44: 599-601.
51. Chugh KS, Sitprija V, Jha V. Acute renal failure in the tropical countries. In: Davison AM, Cameron JS, Grunfeld J-P, Kerr DNS, Ritz E, Winearls CG, eds. Oxford Textbook of Nephrology. 2d ed. Oxford: Oxford University Press, 1998: 1714-1734.
52. Chugh KS, Jha V, Sakhuja V, Joshi K. Acute renal cortical necrosis-a study of 113 patients. Renal Failure 1994; 16: 37-47.
53. Malakar D, Thomas PP, Jacob CK, Shastry JCM. Continuous renal replacement therapy in critically ill patients with renal failure. J Assoc Phys India 1993; 14: 335-336.